Abstract |
To determine whether carvedilol can be safely up-titrated before hospital discharge, we studied 372 consecutive patients with systolic heart failure who were being treated with carvedilol. Carvedilol was initiated a median of 3 days after admission, with a mean starting dose of 12 mg. Up-titration was performed in 67% of patients, with a mean increase of 16 mg and a mean discharge daily dose of 23 +/- 17 mg. Mean daily dose at the end of follow-up was 35.3 +/- 25.3 mg and it increased with higher discharge dose.
|
Authors | Manuel Martínez-Sellés, Tomás Datino, Marta Alhama, Nelida Barrueco, Isabel Castillo, Francisco Fernández-Avilés |
Journal | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
(J Heart Lung Transplant)
Vol. 27
Issue 8
Pg. 914-6
(Aug 2008)
ISSN: 1557-3117 [Electronic] United States |
PMID | 18656807
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carbazoles
- Propanolamines
- Vasodilator Agents
- Carvedilol
|
Topics |
- Aged
- Carbazoles
(therapeutic use)
- Carvedilol
- Dose-Response Relationship, Drug
- Female
- Heart Failure, Systolic
(drug therapy)
- Humans
- Inpatients
- Male
- Middle Aged
- Propanolamines
(therapeutic use)
- Retrospective Studies
- Time Factors
- Titrimetry
- Vasodilator Agents
(therapeutic use)
|